sloan kettering

  • 20140419_KRIS
    April 19, 2014  

    There was word this week of what is being described as a pioneering clinical trial being done in the U.K. for patients with advanced lung cancer. What’s so novel about this development?Hari Sreenivasan spoke to Dr. Mark Kris, an oncologist at Memorial Sloan Kettering Cancer Center, about what makes this clinical trial so interesting. Continue reading

  • November 26, 2008  

    New cancer rates in the United States have declined for the first time and the cancer death rate among men and women has continued to drop, according to a report published Tuesday. A doctor discusses the promising new data with Judy Woodruff. Continue reading